Parallel Health

Featured Article

Microbiome startups respond as industry is accused of ‘questionable practices’

The biotech sector has embraced the microbiome in recent years, a green field market powered by cheap genome sequencing and venture dollars, promising bespoke treatments for everything from gut troubles to skin problems. But a report in Science alleges that these companies lack scientific rigor and meaningful regulation, offering little more than guesswork on a…

11:13 am PDT • March 14, 2024
Microbiome startups respond as industry is accused of ‘questionable practices’

Leveraging resources such as virtual data rooms and shared labs makes it easier for biotech startups to grow. This is good news: We need more companies attacking cancer from novel…

Y Combinator wants 100 times more MRI scans

Featured Article

Here are the 6 finalists of Startup Battlefield at Disrupt 2023

During the last two days, 20 startups pitched their companies as part of TechCrunch Startup Battlefield at Disrupt 2023. These 20 companies were selected as the best of the Startup Battlefield 200 and competed for a chance to take home the Startup Battlefield Cup and $100,000. Expert judges asked the hard questions after the onstage…

7:00 pm PDT • September 20, 2023
Here are the 6 finalists of Startup Battlefield at Disrupt 2023

Featured Article

Parallel Health takes a biotech-forward approach to skincare with custom phage therapy

Parallel Health turns the microbiome of the skin from creepy fact to potentially transformative skin care with custom phage therapy.

10:55 am PDT • September 20, 2023
Parallel Health takes a biotech-forward approach to skincare with custom phage therapy

I’m thrilled to announce the Startup Battlefield 20 companies, pitching at TechCrunch Disrupt 2023. After last year’s big hit, TechCrunch editorial hand-selected 200 startups, out of thousands of applicants, to…

Introducing the 2023 Startup Battlefield Top 20 onstage at TechCrunch Disrupt